Carasent ASA

DB:C34 Stock Report

Market Cap: €112.6m

Carasent Future Growth

Future criteria checks 4/6

Carasent is forecast to grow earnings and revenue by 104.1% and 14.9% per annum respectively. EPS is expected to grow by 103.6% per annum. Return on equity is forecast to be 4.2% in 3 years.

Key information

104.1%

Earnings growth rate

103.6%

EPS growth rate

Healthcare Services earnings growth25.7%
Revenue growth rate14.9%
Future return on equity4.2%
Analyst coverage

Low

Last updated23 Aug 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:C34 - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202636550481012
12/31/20253193332822
12/31/2024271-87482
6/30/2024254-10-3319N/A
3/31/2024251-56-61-4N/A
12/31/2023244-46-74-4N/A
9/30/2023235-64-86-3N/A
6/30/2023227-49-8310N/A
3/31/20232105-7127N/A
12/31/202219531-5834N/A
9/30/202217947-4037N/A
6/30/202216815-2936N/A
3/31/202215433-347N/A
12/31/20211370-632N/A
9/30/2021117-33-129N/A
6/30/202198-211133N/A
3/31/202183-46221N/A
12/31/202071-38319N/A
9/30/202064-14521N/A
6/30/202058-4318N/A
3/31/2020523115N/A
12/31/2019483212N/A
9/30/2019442211N/A
6/30/201940017N/A
3/31/201935-3-32N/A
12/31/201824-7-20N/A
9/30/201814123031N/A
6/30/20186185152N/A
3/31/2018N/A19N/A52N/A
12/31/2017N/A20N/A51N/A
9/30/201725128N/A-6N/A
6/30/201779131N/A-16N/A
3/31/2017136139N/A-24N/A
12/31/2016194142N/A-36N/A
9/30/20162053N/A-33N/A
6/30/201623456N/A-60N/A
3/31/201625956N/A-42N/A
12/31/201530561N/A-32N/A
9/30/2015322-31N/A4N/A
6/30/2015307-80N/A24N/A
3/31/2015314-84N/A22N/A
12/31/2014294-79N/A24N/A
9/30/20142552N/A25N/A
6/30/20142482N/A23N/A
3/31/20142463N/A23N/A
12/31/20132545N/A29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: C34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).

Earnings vs Market: C34 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: C34 is expected to become profitable in the next 3 years.

Revenue vs Market: C34's revenue (14.9% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: C34's revenue (14.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: C34's Return on Equity is forecast to be low in 3 years time (4.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y